Cutaneous fixed drug eruption to paclitaxel; A case report

European Journal of Gynaecological Oncology

Volumn 21, Issue 2, 2000, Pages 190-191

  Baykal, C ^a   Erkek, E ^a   Tutar, E ^a   Yuce K ^a   Ayhan, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cutaneous reactions; Side effects; Taxanes

Indexed keywords

CORTICOSTEROID; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CARCINOMA;

ADENOCARCINOMA; ADRENAL CORTEX HORMONES; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; DRUG ERUPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL; TREATMENT OUTCOME;

EID: 0034054136     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Prond L. C., Stater G.: "Ducataxel: Single agent activity, development of comb, treatment and reducing side-effects". Cancer Treat. Rev., 1995, 21, 463.
2. Bookman M. A., Kloth D. D., Kover P. E., Smolinski S., Ozols R. F.: "Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions". Seminars in Oncology. Dec. 1997, 24 (6 Suppl. 19), S19-13-S19-15.
3. Breatnach S. M.: "Drug reactions". In: Champion R. H., Burton J. L., Burns D. A., Breatnach S. M., eds. Rook Wilkinson Ebling Textbook of Dermatology. 6th ed., Milan. Blackwell Science Ltd., 1998, 3378.
4. Breatnach S. M.: "Drug reactions". In: Champion R. H., Burton J. L.. Burns D. A., Breatnach S. M. eds. Rook Wilkinson Ebling Textbook of Dermatology. 6th ed., Milan, Blackwell Science Ltd., 1998, 3367.
5. Weiss R. B., Bruno S.: "Hypersensitivity reactions to cancer chemotherapeutic agents". Ann. Inten. Med., 1981, 94, 66.
6. Bronner A. K., Hood A. F.: "Cutaneous complications of chemotherapeutic agents". Jour. Am. Acad. Dermatol., 1983, 9, 645.
7. Perry J. R., Warner E.: "Transient encephalopathy after paclitaxel infusion". Neurology, 1996, 46, 1596.
8. Soe M. S., Berkman A.: "Paclitaxel induced myocardial ischemia". Md. Med. J., 1996. 45, 41.
9. Maier-Lenz H., Hauns B., Haering B., Koetting J., Mross K., Unger C., Bauknecht T. et al.: "Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics". Seminars in Oncology, Dec. 1997, 24 (6 Suppl. 19). S19-16-S19-19.